Patient perspectives on dry eye disease and chronic ocular surface pain: Insights from a virtual community-moderated dialogue

Author:

Caffery Barbara1,Petris Rebecca2,Hammitt Katherine M3,Montecchi-Palmer Michela4,Haque Sameena5,Malkowski Jean-Pierre6,Barabino Stefano7ORCID

Affiliation:

1. Toronto Eye Care, Toronto, ON, Canada

2. The Dry Eye Foundation, Poulsbo, WA, USA

3. Sjögren’s Foundation, Reston, VA, USA

4. Novartis Pharmaceuticals Corporation, Fort Worth, TX, USA

5. Novartis Pharmaceuticals, London, UK

6. Novartis Pharma AG, Basel, Switzerland

7. Ospedale L. Sacco-Università di Milano, Milan, Italy

Abstract

Purpose To understand patients’ perspectives on living with dry eye disease (DED), and on the unmet needs in DED and chronic ocular surface pain (COSP) management. Methods A moderated, structured discussion with patients with ocular surface diseases and healthcare professionals (HCPs) was conducted using a virtual platform to capture patients’ journey with DED, their opinion on unmet needs, and design and conduct of clinical trials in DED and COSP. Results Nine participants, including four patient representatives from patient organisations, one ophthalmologist and one optometrist participated in the discussion. Patients had DED of varying severity and aetiology; three patients had Sjögren's. Over 4 weeks, 785 posts were entered on the platform. Prior to diagnosis, patients rarely associated their symptoms with DED. Convenience and symptomatic relief scored higher than treating the disease. Patients expressed the need for plain language information and dialogue with knowledgeable and sensitive HCPs. Online forums and social media were suggested as key recruitment resources, whereas convenience and safety concerns were highlighted as main barriers to enrolment. The need for the inclusion of outcome measures that have a real impact on patients’ experience of their condition was highlighted. Both target product profiles were received positively by participants, highlighting the twice-daily dosing regimen and convenience of the products. Participants acknowledged the value of digital tools and suggested the need to feel valued post-trial. Conclusions This moderated dialogue provided actionable insights on the unmet needs in DED and useful inputs for consideration when designing future clinical trials for DED and COSP.

Funder

Novartis Pharma AG, Basel

Publisher

SAGE Publications

Subject

Ophthalmology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3